ZA932757B - Agents for treating substance abuse disorders - Google Patents
Agents for treating substance abuse disordersInfo
- Publication number
- ZA932757B ZA932757B ZA932757A ZA932757A ZA932757B ZA 932757 B ZA932757 B ZA 932757B ZA 932757 A ZA932757 A ZA 932757A ZA 932757 A ZA932757 A ZA 932757A ZA 932757 B ZA932757 B ZA 932757B
- Authority
- ZA
- South Africa
- Prior art keywords
- pct
- abuse
- agents
- substance abuse
- abuse disorders
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Psychiatry (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Addiction (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Steroid Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyridine Compounds (AREA)
- Compounds Of Unknown Constitution (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9201239A SE9201239D0 (sv) | 1992-04-21 | 1992-04-21 | Agents for treating substance abuse disorders |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA932757B true ZA932757B (en) | 1993-10-28 |
Family
ID=20386004
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA932757A ZA932757B (en) | 1992-04-21 | 1993-04-20 | Agents for treating substance abuse disorders |
Country Status (26)
Country | Link |
---|---|
US (1) | US5565455A (ja) |
EP (1) | EP0637242B1 (ja) |
JP (1) | JP3245642B2 (ja) |
KR (1) | KR100321319B1 (ja) |
AT (1) | ATE184484T1 (ja) |
AU (1) | AU659941B2 (ja) |
BG (1) | BG62154B1 (ja) |
BR (1) | BR9306361A (ja) |
CA (1) | CA2118512C (ja) |
CZ (1) | CZ281296B6 (ja) |
DE (1) | DE69326459T2 (ja) |
DK (1) | DK0637242T3 (ja) |
EE (1) | EE02974B1 (ja) |
ES (1) | ES2139007T3 (ja) |
GR (1) | GR3032030T3 (ja) |
HU (1) | HU223463B1 (ja) |
IL (1) | IL105449A (ja) |
NO (2) | NO308827B1 (ja) |
PH (1) | PH31051A (ja) |
RO (1) | RO117150B1 (ja) |
RU (1) | RU2126254C1 (ja) |
SE (1) | SE9201239D0 (ja) |
SK (1) | SK279940B6 (ja) |
UA (1) | UA27884C2 (ja) |
WO (1) | WO1993020821A1 (ja) |
ZA (1) | ZA932757B (ja) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5316759A (en) * | 1986-03-17 | 1994-05-31 | Robert J. Schaap | Agonist-antagonist combination to reduce the use of nicotine and other drugs |
SE9201956D0 (sv) * | 1992-06-25 | 1992-06-25 | Kabi Pharmacia Ab | Novel nicotinicacid esters |
SE9601708D0 (sv) * | 1996-05-06 | 1996-05-06 | Pharmacia Ab | Pyridyl- and pyrimidyl-piperazines in the treatment of substance abuse disorders |
EE04588B1 (et) | 1997-10-27 | 2006-02-15 | Neurosearch A/S | Heteroarüüldiasatsükloalkaanid kui atsetüülkoliini nikotiinretseptorite kolinergilised ligandid, nende kasutamine ravimitena ning neid sisaldav farmatseutiline kompositsioon |
US6632823B1 (en) * | 1997-12-22 | 2003-10-14 | Merck & Co., Inc. | Substituted pyridine compounds useful as modulators of acetylcholine receptors |
US6344222B1 (en) | 1998-09-03 | 2002-02-05 | Jsr Llc | Medicated chewing gum delivery system for nicotine |
US6358060B2 (en) | 1998-09-03 | 2002-03-19 | Jsr Llc | Two-stage transmucosal medicine delivery system for symptom relief |
US6090780A (en) * | 1999-04-07 | 2000-07-18 | Chandon Prasad | Histidyl-proline diketopiperazine and method of use |
DK1551372T3 (en) | 2002-09-20 | 2018-07-23 | Alpharma Pharmaceuticals Llc | SEQUERATION SUBSTANCES AND RELATED COMPOSITIONS AND PROCEDURES |
EP2526932B1 (en) | 2006-06-19 | 2017-06-07 | Alpharma Pharmaceuticals LLC | Pharmaceutical composition |
US8642016B2 (en) | 2006-07-21 | 2014-02-04 | Jsrnti, Llc | Medicinal delivery system, and related methods |
US8623418B2 (en) | 2007-12-17 | 2014-01-07 | Alpharma Pharmaceuticals Llc | Pharmaceutical composition |
BRPI1003506B1 (pt) | 2010-09-24 | 2019-12-03 | Ache Int Bvi Ltd | composto alquil-piperazino-fenil-4(3h)quinazolinonas e uso do composto alquil-piperazino-fenil-4(3h)quinazolinonas associado aos receptores serotoninérgicos 5-ht1a e 5-ht2a |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2958694A (en) * | 1959-06-22 | 1960-11-01 | Janssen Paul Adriaan Jan | 1-(aroylalkyl)-4-(2'-pyridyl) piperazines |
US2979508A (en) * | 1959-10-12 | 1961-04-11 | Paul A J Janssen | Heterocyclic derivatives of 1-phenyl-omega-(piperazine) alkanols |
US2985657A (en) * | 1959-10-12 | 1961-05-23 | Paul A J Janssen | 1-(aroylalkyl)-4-heterocyclylpiperazines |
NO154582C (no) * | 1978-10-20 | 1986-11-05 | Ferrosan Ab | Analogifremgangsmaate for fremstilling av terapeutisk aktive difenyl-dibutylpiperazinkarboksamider. |
US4605655A (en) * | 1984-03-06 | 1986-08-12 | Bristol-Myers Company | Antipsychotic 1-fluorophenylbutyl-4-(2-pyrimidinyl)piperazine derivatives |
US4766215A (en) * | 1987-02-27 | 1988-08-23 | American Home Products Corporation | Histamine H1 -receptor antagonists |
SE8701375D0 (sv) * | 1987-04-02 | 1987-04-02 | Leo Ab | Novel pyridyl- and pyrimidyl derivatives |
US5217987A (en) * | 1989-10-30 | 1993-06-08 | Berger Stephen P | Dopamine uptake inhibitors in reducing substance abuse and/or craving |
SE9100860D0 (sv) * | 1991-03-22 | 1991-03-22 | Kabi Pharmacia Ab | New use |
-
1992
- 1992-04-21 SE SE9201239A patent/SE9201239D0/xx unknown
-
1993
- 1993-04-19 RU RU94045866A patent/RU2126254C1/ru active
- 1993-04-19 JP JP51825193A patent/JP3245642B2/ja not_active Expired - Fee Related
- 1993-04-19 ES ES93911554T patent/ES2139007T3/es not_active Expired - Lifetime
- 1993-04-19 EP EP93911554A patent/EP0637242B1/en not_active Expired - Lifetime
- 1993-04-19 CA CA002118512A patent/CA2118512C/en not_active Expired - Fee Related
- 1993-04-19 US US08/325,212 patent/US5565455A/en not_active Expired - Lifetime
- 1993-04-19 SK SK1269-94A patent/SK279940B6/sk not_active IP Right Cessation
- 1993-04-19 RO RO94-01692A patent/RO117150B1/ro unknown
- 1993-04-19 HU HU9403020A patent/HU223463B1/hu not_active IP Right Cessation
- 1993-04-19 UA UA94105949A patent/UA27884C2/uk unknown
- 1993-04-19 AT AT93911554T patent/ATE184484T1/de not_active IP Right Cessation
- 1993-04-19 DK DK93911554T patent/DK0637242T3/da active
- 1993-04-19 CZ CZ942606A patent/CZ281296B6/cs not_active IP Right Cessation
- 1993-04-19 WO PCT/SE1993/000339 patent/WO1993020821A1/en active IP Right Grant
- 1993-04-19 DE DE69326459T patent/DE69326459T2/de not_active Expired - Fee Related
- 1993-04-19 AU AU40437/93A patent/AU659941B2/en not_active Ceased
- 1993-04-19 IL IL105449A patent/IL105449A/en not_active IP Right Cessation
- 1993-04-19 BR BR9306361A patent/BR9306361A/pt not_active Application Discontinuation
- 1993-04-20 ZA ZA932757A patent/ZA932757B/xx unknown
- 1993-04-21 PH PH46084A patent/PH31051A/en unknown
-
1994
- 1994-10-19 BG BG99129A patent/BG62154B1/bg unknown
- 1994-10-20 NO NO943977A patent/NO308827B1/no not_active IP Right Cessation
- 1994-10-21 KR KR1019940703758A patent/KR100321319B1/ko not_active IP Right Cessation
- 1994-11-17 EE EE9400398A patent/EE02974B1/xx not_active IP Right Cessation
-
1999
- 1999-12-02 GR GR990403117T patent/GR3032030T3/el unknown
-
2000
- 2000-08-21 NO NO20004169A patent/NO318461B1/no not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GR3032030T3 (en) | Agents for treating substance abuse disorders. | |
GR3035805T3 (en) | New use of diphenylbutylpiperazinecarboxamides in the treatment of substance disorders. | |
MY109862A (en) | A short infusion methods for administration of paclitaxel | |
HU9603042D0 (en) | Use of certain methanebisphosphonic acid derivatives to prevent or for treatment of prosthesis loosening and prosthesis migration | |
Coccaro | Psychopharmacological studies in patients with personality disorders: Review and perspective. | |
DE3778008D1 (de) | Ketonderivate als arzneimittel zur behandlung oder vorbeugung des entzugssyndromes. | |
ZA925146B (en) | Pharmaceutical agent for treatment of withdrawal symptoms. | |
NO943293L (no) | Anvendelse av et medikament ved avvenning mot röyk | |
Baughman | The safety record of buspirone in generalized anxiety disorder. | |
King | AZT delta study: major European/Australian study finds combinations better than AZT alone | |
DE69307705D1 (de) | Verwendung von 3,5-diamino-6-(2,3-dichlorophenyl)-1,2,4,-triazinisethionat zur behandlung und vorbeugung von drogenabhaengigkeit,-toleranz und- sensibilisierung | |
Jeanmonod et al. | The drug dependent prisoner: Medical treatment and its limits | |
MX9703032A (es) | Nuevas aplicaciones del 5-etoxicarbonil-2,4,6-trimetil-1,4-dihidropiridina-3-carboxi lato de 2-[n-(1,2-benzisotiazolil-3(2h) ona-1,1-dioxido]etilo. | |
RU95116161A (ru) | Способ лечения синдрома диссеминированного внутрисосудистого микротромбоза при тяжелой изолированной и сочетанной черепно-мозговой травме |